 antitumor activ interferon alpha beta gamma combin human melanoma cell vitro chang prolifer melanin synthesi immunophenotyp antitumor activ human interferon ifn alpha beta combin human melanoma cell line variou concentr iu/ml ifn alpha iu/ml ifn beta iu/ml ifn gamma vitro experi ifn beta potent antiprolif effect ifn incub growth inhibit iu/ml natur ifn beta u/ml recombin ifn gamma dose iu/ml recombin ifn alpha growth inhibit strong synergist antiprolif activ combin ifn alpha ifn gamma ifn beta ifn gamma none ifn induc termin differenti melanoma cell vitro format dendrit portion differenti cell vitro treatment ifn comparison untreat control untreat control portion differenti cell treatment ifn alpha ifn beta ifn gamma melanin synthesi treatment ifn alpha untreat control treatment ifn alpha treatment ifn beta ifn gamma cell surfac marker ifn hla-i antigen ifn ifn beta potent induc ifn gamma express hla-dr -dq antigen express molecul melanoma progress marker find aggress phenotyp melanoma cell